Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1974 1
1976 1
1984 1
1985 2
1988 2
1991 2
1992 1
1993 2
1994 1
1995 2
1999 1
2003 1
2010 2
2011 1
2012 1
2013 3
2016 2
2017 1
2018 1
2020 1
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Results by year

Filters applied: . Clear all
Page 1
Impact of concomitant medications on the efficacy of immune checkpoint inhibitors: an umbrella review.
Li H, Zhang L, Yang F, Zhao R, Li X, Li H. Li H, et al. Front Immunol. 2023 Sep 29;14:1218386. doi: 10.3389/fimmu.2023.1218386. eCollection 2023. Front Immunol. 2023. PMID: 37841249 Free PMC article.
Class III evidence suggested that proton pump inhibitors have a negative impact on ICIs efficacy; nevertheless, the efficacy against melanoma and renal cell carcinoma was not affected, and the effect was related to exposure before the initiation of ICIs thera …
Class III evidence suggested that proton pump inhibitors have a negative impact on ICIs efficacy; nevertheless, the efficacy against melanom …
Non-aspirin non-steroidal anti-inflammatory drugs for the primary chemoprevention of non-gastrointestinal cancer: summary of evidence.
Silva MT, Galvao TF, Zimmerman IR, Pereira MG, Lopes LC. Silva MT, et al. Curr Pharm Des. 2012;18(26):4047-70. doi: 10.2174/138161212802083699. Curr Pharm Des. 2012. PMID: 22632754 Review.
Due to their similar pharmacodynamics, the use of other non-steroidal anti-inflammatory drugs (NSAIDs) has been suggested for other cancer sites. ...In contrast, an increased risk of renal cell carcinoma and a reduced risk of breas …
Due to their similar pharmacodynamics, the use of other non-steroidal anti-inflammatory drugs (NSAIDs) has been …
Epidemiology of non-steroidal anti-inflammatory drugs and cancer.
Baron JA. Baron JA. Prog Exp Tumor Res. 2003;37:1-24. doi: 10.1159/000071364. Prog Exp Tumor Res. 2003. PMID: 12795046 Review.
There is evidence that aspirin--and apparently other NSAIDs--may be protective agents against cancer in the gastrointestinal tract. ...More extensive data have been generated regarding the effect of NSAIDs--largely salicylates--on renal cell carcino …
There is evidence that aspirin--and apparently other NSAIDs--may be protective agents against cancer in the gastrointestinal t …
Aspirin restores ABT-737-mediated apoptosis in human renal carcinoma cells.
Ou YC, Li JR, Wang JD, Chen WY, Kuan YH, Yang CP, Liao SL, Lu HC, Chen CJ. Ou YC, et al. Biochem Biophys Res Commun. 2018 Jul 12;502(2):187-193. doi: 10.1016/j.bbrc.2018.05.142. Epub 2018 May 24. Biochem Biophys Res Commun. 2018. PMID: 29792865
Aspirin is a novel chemopreventive agent against malignancy. However, outcomes of aspirin monotherapy of renal cell carcinoma (RCC) are inconsistent across studies. ...Cancer cells including those from RCC, that have high levels of Mcl-1, are re …
Aspirin is a novel chemopreventive agent against malignancy. However, outcomes of aspirin monotherapy of renal cell …
A large cohort study of nonsteroidal anti-inflammatory drugs and renal cell carcinoma incidence in the National Institutes of Health-AARP Diet and Health Study.
Liu W, Park Y, Purdue MP, Giovannucci E, Cho E. Liu W, et al. Cancer Causes Control. 2013 Oct;24(10):1865-73. doi: 10.1007/s10552-013-0263-4. Epub 2013 Jul 19. Cancer Causes Control. 2013. PMID: 23868221 Free PMC article.
AIM: Existing epidemiologic evidence for the association between nonsteroidal anti-inflammatory drugs (NSAIDs) and renal cell carcinoma (RCC) risk is inconsistent. ...No statistically significant associations between the use of aspirin or …
AIM: Existing epidemiologic evidence for the association between nonsteroidal anti-inflammatory drugs (NSAIDs) and renal …
Analgesic use and risk of renal cell carcinoma: A case-control, cohort and meta-analytic assessment.
Karami S, Daughtery SE, Schwartz K, Davis FG, Ruterbusch JJ, Wacholder S, Graubard BI, Berndt SI, Hofmann JN, Purdue MP, Moore LE, Colt JS. Karami S, et al. Int J Cancer. 2016 Aug 1;139(3):584-92. doi: 10.1002/ijc.30108. Epub 2016 Apr 9. Int J Cancer. 2016. PMID: 27009534 Free PMC article.
We investigated the association between renal cell carcinoma (RCC) and analgesic use in a large population-based case-control study and a post-trial observational cohort study. ...We analyzed data from 1,217 RCC cases and 1,235 controls in the US Kidne …
We investigated the association between renal cell carcinoma (RCC) and analgesic use in a large population-based …
Aspirin and risk of renal cell cancer in Italy.
Tavani A, Scotti L, Bosetti C, Dal Maso L, Montella M, Ramazzotti V, Negri E, Franceschi S, La Vecchia C. Tavani A, et al. Eur J Cancer Prev. 2010 Jul;19(4):272-4. doi: 10.1097/CEJ.0b013e3283394750. Eur J Cancer Prev. 2010. PMID: 20351553
Aspirin and nonsteroidal anti-inflammatory drugs have been related to decreased risk of several cancers, but studies on the relation with the risk of renal cell cancer (RCC) are inconsistent. ...The ORs were 0.91 (95% CI 0.55-1.50) in regular us …
Aspirin and nonsteroidal anti-inflammatory drugs have been related to decreased risk of several cancers, but studies on …
The role of metabolic activation of analgesics and non-steroidal anti-inflammatory drugs in the development of renal papillary necrosis and upper urothelial carcinoma.
Bach PH, Bridges JW. Bach PH, et al. Prostaglandins Leukot Med. 1984 Aug;15(2):251-74. doi: 10.1016/0262-1746(84)90182-3. Prostaglandins Leukot Med. 1984. PMID: 6436833
There has been no cogent hypothesis to explain the molecular basis of analgesic and non-steroidal anti-inflammatory drug (NSAID) associated renal papillary necrosis (RPN) and upper urothelial carcinoma (UUC). The microsomal cytochr …
There has been no cogent hypothesis to explain the molecular basis of analgesic and non-steroidal anti-inflam …
Prospective evaluation of analgesic use and risk of renal cell cancer.
Cho E, Curhan G, Hankinson SE, Kantoff P, Atkins MB, Stampfer M, Choueiri TK. Cho E, et al. Arch Intern Med. 2011 Sep 12;171(16):1487-93. doi: 10.1001/archinternmed.2011.356. Arch Intern Med. 2011. PMID: 21911634 Free PMC article.
BACKGROUND: Epidemiologic data suggest that analgesic use increases the risk of renal cell cancer (RCC), but few prospective studies have been published. ...Use of aspirin, other nonsteroidal anti-inflammatory drugs (NSAIDs), and acetamin …
BACKGROUND: Epidemiologic data suggest that analgesic use increases the risk of renal cell cancer (RCC), but few prospe …
Adding Cyclooxygenase Inhibitors to Immune Checkpoint Inhibitors Did Not Improve Outcomes in Metastatic Renal Cell Carcinoma.
Zhang Y, Kumar P, Adashek JJ, Skelton WP 4th, Li J, Vosoughi A, Chahoud J, Manley BJ, Spiess PE. Zhang Y, et al. Cells. 2022 Aug 12;11(16):2505. doi: 10.3390/cells11162505. Cells. 2022. PMID: 36010582 Free PMC article.
Little is known about COX-2 inhibition in response to ICIs in metastatic renal cell carcinoma (mRCC). In this retrospective cohort study, we examined the effect of COX-2 inhibitors on the long-term outcomes of mRCC patients undergoing ICI therapies. ...Among …
Little is known about COX-2 inhibition in response to ICIs in metastatic renal cell carcinoma (mRCC). In this retrospec …
31 results